{
  "docId": "019de070-da34-70fa-b6ea-612c42635c34",
  "docSlug": "1519080da03b1584f82c21fb8b213d00",
  "documentTitle": "Alkermes | Results Presentation Deck | 13 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 13,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-da34-70fa-b6ea-612c42635c34/11",
  "deckHref": "/decks/019de070-da34-70fa-b6ea-612c42635c34",
  "deckJsonHref": "/decks/019de070-da34-70fa-b6ea-612c42635c34.json",
  "deckAnchorHref": "/decks/019de070-da34-70fa-b6ea-612c42635c34#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.056,
        "y": 0.225
      },
      "kind": "list",
      "text": "Mucosal melanoma: Orphan Drug Designation; Initiated ARTISTRY-6 phase 2 study.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0898b48e-a0f6-48b5-86a1-dea0ff084648",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.056,
        "y": 0.415
      },
      "kind": "list",
      "text": "Platinum-resistant ovarian cancer: Collaboration with MSD for phase 3 study with KEYTRUDA.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e1257a7-288c-406a-91e2-d3b9cfddb8ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.056,
        "y": 0.61
      },
      "kind": "list",
      "text": "Operational progress: Completed enrollment in ARTISTRY-1; data accepted for ASCO presentation.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e15ba4d-c242-4974-a7a9-ca4fa6c0b223",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.056,
        "y": 0.125
      },
      "kind": "title",
      "text": "Nemvaleukin Alfa Development Program Progress",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ebcdf7f0-df13-4bf2-834f-f93984700dc7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 12,
      "from": 11,
      "beatId": "1846d218-0b60-4725-b63d-2c7dcdecf94b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "R&D progress",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Slides 11-12 provide an update on the Nemvaleukin Alfa development program and R&D portfolio advancement",
      "position": 2,
      "confidence": 0.7,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}